Camber Capital Management LP
Camber Capital Management LP is a Boston-based hedge fund founded in 2006, specializing in healthcare investments. The firm is known for its rigorous fundamental research, targeting undervalued healthcare companies across biopharmaceuticals, medical devices, and related industries. Camber Capital employs approximately 8-20 professionals and serves institutional investors seeking long-term capital growth through sector-focused equity strategies.
Investment Strategy
Camber Capital Management LP focuses on long-term investments in the healthcare sector, employing in-depth fundamental research and analysis to identify compelling opportunities within healthcare-related stocks, including biotechnology, pharmaceuticals, and medical devices. The firm maintains a concentrated portfolio and seeks to generate strong absolute returns by investing in companies with attractive valuations and growth prospects, leveraging its proximity to Boston's life sciences ecosystem for access to insights and industry trends.
Top Holdings
Equity Positions (23)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
Z ZBH | ZIMMER BIOMET HOLDINGS INC | 8.56% | $91.2M | 1,000,000 | $118.41 | $91.21 | -$163.4M |
B BAX | BAXTER INTL INC | 8.10% | $86.3M | 2,850,000 | $38.07 | $30.28 | -$110.5M |
H HUM | HUMANA INC | 6.89% | $73.3M | 300,000 | $287.88 | $244.48 | -$118.5M |
C CVS | CVS HEALTH CORP | 6.80% | $72.4M | 1,050,000 | $51.52 | $68.98 | -$80.0M |
G GMED | GLOBUS MED INC | 4.43% | $47.2M | 800,000 | $54.74 | $59.02 | -$44.3M |
Options Positions (2)
| Ticker | Security | Action | Type | Notional Value | Contracts | Underlying Price | Premium Paid | Change (Contracts) | Change (Value) |
|---|---|---|---|---|---|---|---|---|---|
S SPY | SPDR S&P 500 ETF TR | Sold | Put | $308.9M | 5,000 | $617.85 | $543.48 | -10,000 | -$530.2M |
G GSK | GSK PLC | — | Call | $38.4M | 10,000 | $38.40 | $33.82 | 0 | -$340.0K |